Hypertriglyceridemic waist increased risk of inappropriate glucose control in patients with coronary heart disease

References

• Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with Type diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339(4), 229–234 (1998).
   Google Scholar
• Mayer O Jr, Bruthans J. Timoracka K. The changes in cardiovascular prevention practice between 1995 and 2012 in the Czech Republic. A comparison of EUROASPIRE I, II, III and IV study, Cor Vasa 56(2), e91–e97 (2014).
   Google Scholar
• Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373(9667), 929–940 (2009).
   Google Scholar
• Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28(7), 1769–1778 (2005).
   Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3), 356–359 (2002).
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009).
   Google Scholar
• Gill H, Mugo M, Whaley-Connell A, Stump C, Sowers JR. The key role of insulin resistance in the cardiometabolic syndrome. Am. J. Med. Sci. 330(6), 290–294 (2005).
   Google Scholar
• Klein S, Allison DB, Heymsfield SB et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am. J. Clin. Nutr. 85(5), 1197–1202 (2007).
   Google Scholar
• Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33(13), 1635–1701 (2012).
   Google Scholar
• Kotseva K, Wood D, De Backer G et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 17(5), 530–540 (2010).
   Google Scholar
• Gazi IF, Milionis HJ, Filippatos TD et al. Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women. Diabetes Metab. Res. Rev. 24(3), 223–230 (2008).
   Google Scholar
• Barter PJ, Brandrup-Wognsen G, Palmer MK, Nicholls SJ. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database J. Lipid Res. 51(6), 1546–1553 (2010).
   Google Scholar
• Lemieux I, Pascot A, Couillard C et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102(2), 179–184 (2000).
   Google Scholar
• Carlsson AC, Riserus U, Arnlov J. Hypertriglyceridemic waist phenotype is associated with decreased insulin sensitivity and incident diabetes in elderly men. Obesity 22(2), 526–529 (2014).
   Google Scholar
• Arsenault BJ, Lemieux I, Després JP et al. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ 182(13), 1427–1432 (2010).
   Google Scholar
• Czernichow S, Bruckert E, Bertrais S, Galan P, Hercberg S, Oppert JM. Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int. J. Obes. 31(5), 791–796 (2007).
   Google Scholar
• He S, Zheng Y, Shu Y, He J, Wang Y, Chen X. Hypertriglyceridemic waist might be an alternative to metabolic syndrome for predicting future diabetes mellitus. PLoS ONE 8(9), e73292 (2013).
   Google Scholar
• Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 111(15), 1883–1890 (2005).
   Google Scholar